Brunswick Corporation vs Nuwellis Inc — how do they compare? Brunswick Corporation trades at $81.32 (market cap $5.21B), while Nuwellis Inc trades at $1.5 (market cap $522.76K). The key difference: Brunswick Corporation is far larger — about 9966.3× Nuwellis Inc's market cap, and Brunswick Corporation pays a 2.19% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| BC | NUWE | |
|---|---|---|
Market Cap | $5.21B | $522.76K |
Sector | Consumer Cyclical | Technology |
52-Week High | $89.22 | $220.50 |
52-Week Low | $58.75 | $1.42 |
Enterprise Value | $7.21B | -$1.29M |
Dividend Yield | 2.19% | — |
Signals from Pluang's Aura AI — not financial advice
BC trades at $81.55, up 0.37% with a bullish technical signal. Recent Q2 2026 earnings beat estimates with EPS of $1.56 versus $1.19 expected. The company maintains a dividend of $0.44 per share and has strong analyst support with 22 buy ratings. However, negative net income margin and ROE highlight profitability challenges amid declining revenue trends from $6.8B in 2022 to $5.4B in 2025.
Outlook is cautiously optimistic due to earnings beats and institutional buying, but high P/E of 73.92 and persistent net losses pose valuation and execution risks. The consensus price target of $85.33 suggests modest upside, contingent on reversing profit declines and stabilizing cash flow.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Brunswick Corp is the leader in several recreational sectors. The firm is the leading boat manufacturer, and its brands include Mercury and Mariner outboard engines
Read more on BC →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →